Meghalayan Medical Drugs And Services Limited - Company Profile

It is a healthcare public limited state government company based in Shillong, Meghalaya, India, established in 2022.
2022 Shillong, Meghalaya, India Active
Last Updated:
Access Report
About Meghalayan Medical Drugs And Services Limited

Meghalayan Medical Drugs And Services Limited, a active public limited state government company, was established on 13 November 2022 in Shillong, Meghalaya, India. Engaging in other hospital and medical care activities within the hospital and medical care sector, it holds CIN: U85300ML2022SGC013895. Registered under ROC Roc Guwahati. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹0.50 M.

It upholds a compliant status. Its leadership includes Lumlang Thangkhiew (Nominee Director), Ramakrishna Chitturi (Managing Director), Joram Beda (Director). Past directors included Rilynti Lyngdoh, Rafellia Allya, Rosetta Mary Kurbah. It holds ₹6.19 Cr open charges and no settled loans. Its latest AGM occurred on 11 September 2025, with the balance sheet filed on 31 March 2024. It is based at Pasteur Hiils, Lawmali, Shillong, Meghalaya, 793001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U85300ML2022SGC013895

  • Registration Number

    013895

  • Incorporation Date

    13 November 2022

  • Authorized Capital

    ₹1.50 M

  • Paid-Up Capital

    ₹0.50 M

  • ROC Code

    Roc Guwahati

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.50 M
  • Paid Up Capital ₹ 0.50 M
  • Company Age 3 Year, 3 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 6.19 Cr
Company report

Meghalayan Medical Drugs And Services Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Meghalayan Medical Drugs And Services Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Meghalayan Medical Drugs And Services Limited?
Current Directors
Name Designation Appointment Date Status
Lumlang Thangkhiew Nominee Director 01 Sep 2023 Current
Ramakrishna Chitturi Managing Director 11 Apr 2025 Current
Joram Beda Director 13 Nov 2022 Current
Sampath Kumar Pamu Director 13 Nov 2022 Current
Janupribalas S Momin Nominee Director 22 May 2024 Current
Neela Ewon Kharsahnoh Nominee Director 27 Feb 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Nominee Director 11 Apr 2025 Past
Pramod Abcsdd Nominee Director 01 Mar 2024 Past
Pramod Abcsdd Director 22 May 2024 Past
Pramod Abcsdd Managing Director 11 Apr 2025 Past
Pramod Abcsdd Nominee Director 27 Feb 2025 Past
Pramod Abcsdd Nominee Director 27 Feb 2025 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Meghalayan Medical Drugs And Services.

Enhance accessibility to Meghalayan Medical Drugs And Services's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Meghalayan Medical Drugs And Services revenue growth over time
Meghalayan Medical Drugs And Services profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Meghalayan Medical Drugs And Services?

In 2023, Meghalayan Medical Drugs And Services had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹61,893,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Others : 6.19 Cr
Latest Charge Details
Date Lender Amount Status
09 Sep 2024 Others ₹6.19 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Meghalayan Medical Drugs And Services?

Meghalayan Medical Drugs And Services has a workforce of 0 employees as of Oct 24, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Meghalayan Medical Drugs And Services, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Meghalayan Medical Drugs And Services's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Meghalayan Medical Drugs And Services
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Meghalayan Medical Drugs And Services Limited last Annual general meeting of members was held on 11 Sep 2025 as per latest MCA records. was documented.

  • Director Appointment

    Progress on Ramakrishna Chitturi was appointed as a Managing Director was appointed as a Managing Director on 11 Apr 2025 & has been associated with this company since 11 months 1 day . was documented.

  • Director Appointment

    Progress on Neela Ewon Kharsahnoh was appointed as a Nominee Director was appointed as a Nominee Director on 27 Feb 2025 & has been associated with this company since 1 year 13 days . was documented.

  • Director Appointment

    Lumrilyne Mylliem Umlong was appointed as a Nominee Director was appointed as a Nominee Director on 27 Feb 2025 & has been associated with this company since 1 year 13 days . was recorded as a recent event.

  • Charges

    A charge with Others amounted to Rs. 61.89 M with Charge ID 100998118 was registered on 09 Sep 2024. was recorded as a recent event.

  • Director Appointment

    The activity Janupribalas S Momin was appointed as a Nominee Director was appointed as a Nominee Director on 22 May 2024 & has been associated with this company since 1 year 9 months . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Meghalayan Medical Drugs And Services Limited?

The CIN of Meghalayan Medical Drugs And Services Limited is U85300ML2022SGC013895.

Where is Meghalayan Medical Drugs And Services Limited headquartered?

Meghalayan Medical Drugs And Services Limited is headquartered at Pasteur Hiils, Lawmali, Shillong, Meghalaya, 793001.

When was Meghalayan Medical Drugs And Services Limited incorporated?

Meghalayan Medical Drugs And Services Limited was incorporated on 13 November 2022.

Who are the current directors of Meghalayan Medical Drugs And Services Limited?

The current directors of Meghalayan Medical Drugs And Services Limited are

What is the primary industry of Meghalayan Medical Drugs And Services Limited?

The primary industry of Meghalayan Medical Drugs And Services Limited is Hospital And Medical Care.

Is Meghalayan Medical Drugs And Services Limited a listed company?

Meghalayan Medical Drugs And Services Limited is unlisted.

What is the capital structure of Meghalayan Medical Drugs And Services Limited?

The authorized capital of Meghalayan Medical Drugs And Services Limited is ₹1.50 M, and the paid-up capital is ₹0.50 M.

What is the compliance status of Meghalayan Medical Drugs And Services Limited?

The compliance status of Meghalayan Medical Drugs And Services Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available